ALKERMES reported $22.9M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -42.78M 23.1M
Amgen AMGN:US $ 3188M 218M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ 41.16M 14.24M
Bluebird Bio BLUE:US $ -234.8M 9.32M
Bristol Myers Squibb BMY:US $ 5679M 455M
Coherus Biosciences CHRS:US $ -23.29M 143.22M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Gilead Sciences GILD:US $ 2816M 669M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
H. Lundbeck A/S LUN:DC 995M 357M
Heron Therapeutics HRTX:US $ -59.74M 8.36M
Horizon Pharma HZNP:US $ 305.69M 324.32M
Intra Cellular Therapies ITCI:US $ -69.02M 15.92M
JAZZ PHA JAZZ:US $ 77.72M 157.36M
Johnson & Johnson JNJ:US $ 8192M 2043M
Marinus Pharmaceuticals MRNS:US $ -23.4M 3.68M
Minerva Neurosciences NERV:US $ -8.96M 1.46M
Nektar Therapeutics NKTR:US $ -106.66M 0.81M
Neurocrine Biosciences NBIX:US $ 70.4M 36.4M
Otsuka Holdings 4578:JP Y 80272M 14755M
Pfizer PFE:US $ 7593M 610M
Regeneron Pharmaceuticals REGN:US $ 3418.3M 2238.2M
Revance Therapeutics RVNC:US $ -65.29M 0.48M
Teva Pharmaceutical Industries TEVA:US $ 1136M 34M
Vertex Pharmaceuticals VRTX:US $ -5.12M 917.88M
Zogenix ZGNX:US $ -53.07M 3.63M